Low Back Pain - What's Next? Stratified Care Compared to Current Practice

NCT02612467 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 333

Last updated 2019-09-10

No results posted yet for this study

Summary

Background Studies in the United Kingdom find the stratified care model of the STarT Back Tool (SBT) to be superior to usual care in primary care low back pain (LBP) patients. However, considerations on differences in health care and social systems across countries are required before taking steps towards any recommendations of implementing stratified care into other health care services.

Objective To investigate the effectiveness of the stratified care model of the SBT, when embedded into the regional disease management programs on LBP in primary care as compared to current best practice care.

Conditions

  • Low Back Pain

Interventions

OTHER

Stratified care

Patients are stratified according to the SBT subgroups (low, medium and high risk) and the appropriate matched intervention will be delivered accordingly. Low risk: Reassuring information. Onwards referral, investigation or further treatment is not recommended Medium risk: In addition to reassuring information patients receive evidence based individualised treatment focusing on restoring function (targeting back pain, leg pain, co-morbid pain and disability) High risk : In addition to medium risk treatment patients will receive individualised psychologically informed physiotherapy aiming to reduce pain and disability.

OTHER

Current care

Treatment based on clinical judgement, clinical need and patient preferences. No access to guidance tools.

Sponsors & Collaborators

  • Herning Hospital

    collaborator OTHER
  • Research Unit of General Practice, Odense

    collaborator OTHER
  • Spine Centre of Southern Denmark

    collaborator OTHER
  • Keele University

    collaborator OTHER
  • Region of Southern Denmark

    lead OTHER

Principal Investigators

  • Lars Morsø, Ph.D · Centre for Quality, Institute for Regional Healthresearch

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2018-12-15
Completion
2018-12-15

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02612467 on ClinicalTrials.gov